trending Market Intelligence /marketintelligence/en/news-insights/trending/krm1lzumplqtzgtu1o6n7q2 content esgSubNav
In This List

Marinus adds former Pacira Pharmaceuticals COO to board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Marinus adds former Pacira Pharmaceuticals COO to board

Marinus Pharmaceuticals Inc. appointed Scott Braunstein to its board.

Braunstein currently serves as an operating partner at Aisling Capital Management LP, a New York-based venture capital and private equity firm.

Prior to joining Aisling, Braunstein was the COO of Pacira Pharmaceuticals Inc., a Parsippany, N.J.-based specialty pharmaceutical company that develops and manufactures products for acute care practitioners and their patients.

Radnor, Pa.-based Marinus Pharmaceuticals is focused on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders.